ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Xvivo Perfusion AB

Xvivo Perfusion AB (0RKL)

106,00
0,00
( 0,00% )
Mis à jour : 02:00:00

Xvivo Perfusion AB (0RKL) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
106,00
( - )
Prix Achat
106,00
Prix Vente
106,00
Volume échangé
5 782
0,00 Fourchette du Jour 0,00
106,00 Plage de 52 semaines 106,00
Cap du marché
Clôture Veille
106,00
Ouverture
-
Dernière Transaction
22
@
253.6
(O)
Dernière heure de transaction
15:30:44
Volume financier
-
VWAP
-
Volume moyen (3 m)
SEK 97 832
Actions en circulation
31 499 470
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
116,52
Bénéfice par action (BPA)
2,34
Chiffre d'affairess (LTM)
834,53M
Bénéfice net (LTM)
73,86M

À propos de Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers K... Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. Xvivo Perfusion AB (publ) was incorporated in 1998 and is headquartered in Mölndal, Sweden. Show more

Secteur
-
Industrie
-
Siège social
Mölndal, Sweden
Fondé
1998
Xvivo Perfusion AB est coté dans le secteur de la London Stock Exchange avec le ticker 0RKL. Le dernier cours de clôture d'Xvivo Perfusion AB était de SEK106,00. Au cours de la dernière année, les actions de Xvivo Perfusion AB ont été négociées dans une fourchette de prix de SEK 106,00 à SEK 106,00.

Xvivo Perfusion AB compte actuellement 31 499 470 actions en circulation. La capitalisation boursière d'Xvivo Perfusion AB est de SEK3,34 milliard. Xvivo Perfusion AB a un ratio cours/bénéfice (ratio PE) de 116.52.

0RKL Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DE
40000000DE
120000000DE
26001061061067060106DE
52001061061067972106DE
156001061061066061106DE
260001061061064230106DE

0RKL - Frequently Asked Questions (FAQ)

What is the current Xvivo Perfusion AB share price?
The current share price of Xvivo Perfusion AB is SEK 106,00
How many Xvivo Perfusion AB shares are in issue?
Xvivo Perfusion AB has 31 499 470 shares in issue
What is the market cap of Xvivo Perfusion AB?
The market capitalisation of Xvivo Perfusion AB is SEK 3,34B
What is the 1 year trading range for Xvivo Perfusion AB share price?
Xvivo Perfusion AB has traded in the range of SEK 106,00 to SEK 106,00 during the past year
What is the PE ratio of Xvivo Perfusion AB?
The price to earnings ratio of Xvivo Perfusion AB is 116,52
What is the cash to sales ratio of Xvivo Perfusion AB?
The cash to sales ratio of Xvivo Perfusion AB is 10,3
What is the registered address of Xvivo Perfusion AB?
The registered address for Xvivo Perfusion AB is Gemenskapens gata 9, Mölndal, Västra Götaland County, 431 53
What is the Xvivo Perfusion AB website address?
The website address for Xvivo Perfusion AB is www.xvivogroup.com

0RKL Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock